Home LiteratureArticle Details
PMID: 3874293 Published · ppublish English Journal Article

Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.

JAMA ·Vol. 254 ·No. 4 ·1985-07-26 ·Pages 509-14

Fleming DW, Leibenhaut MH, Albanes D, Cochi SL, Hightower AW, Makintubee S, Helgerson SD, Broome CV

Abstract

The risk factors for acquisition of secondary day-care-associated Haemophilus influenzae type b disease were evaluated in a cohort of children in Seattle-King County, Washington; Atlanta; and the state of Oklahoma. During the study period, 129 primary cases were identified in children less than 5 years old who attended day-care facilities. In ten instances (8%), a secondary case occurred between one and 60 days after a primary case in the same classroom. Risk of secondary disease in classroom contacts was strongly age related: 2.4% in children 0 to 11 months old, 1.2% in children 12 to 23 months old, and 0.0% in children 24 to 59 months old. Controlling for age, children attending day-care more hours per week were more likely to transmit or acquire secondary disease. Risk of secondary disease for children in other classrooms at a center where a case had occurred was not significantly greater than risk of primary disease. Administration of rifampin to classroom contacts of a child with invasive H influenzae was effective in preventing secondary cases (95% confidence interval for rifampin efficacy, 47% to 100%). For children 0 to 23 months old not treated with rifampin, risk of secondary disease was 2.7% (95% confidence interval, 1.1% to 4.3%), a risk approaching that reported in household contacts.

MeSH Terms
Age Factors Bacterial Outer Membrane Proteins/analysis Child Day Care Centers Child, Preschool Georgia Haemophilus Infections/prevention & control,transmission Haemophilus influenzae/classification Humans Infant Infant, Newborn Meningitis, Haemophilus/transmission Oklahoma Rifampin/therapeutic use Risk Time Factors Washington
Chemicals
Bacterial Outer Membrane Proteins Rifampin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Fleming D W
Leibenhaut M H
Albanes D
Cochi S L
Hightower A W
Makintubee S
Helgerson S D
Broome C V
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1985-07-26
Pages
509-14
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]